Not Signed In - Twice-Daily Dosing Of Xibrom(TM) As Equivalent To Four Times A Day Of Other Treatments, Study
Fri, 05 May 2006 06:00 AM EST
... ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA) announced today the presentation of data from aphysician- sponsored clinical trial designed to compare the efficacy ofXibrom(TM) (bromfenac ophthalmic solution) 0.09% with two topicalnon-steroidal anti- inflammatory solutions (NSAIDs) that were given fourtimes a day for the treatment of acute pseudophakic cystoid macular edema(CME)... click link for more info. ...
Related Topics
- Day Care
- Child Day Care
- Prayer
- Five a Day Fruits and Vegetables
- Carcinogens
- Daily Supplements
- Daily Supplement Dosages
- Daily Bladder Diary
- Home Care
- Procaine
- Child Care
- ARDS
- Radiation Studies
- AIDS - Living and Coping
- Three-Day Measles
- Riley-Day Syndrome
- Aerosol Treatments
- Facial Treatments
- Alternative Treatments
- Treatments
email this page
print this page
bookmark this page
feedback on this page
